Thursday, December 17, 2020

High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?

Alexandros G.Sfakianakis shared this article with you from Inoreader

?image=000512373-1.jpg


Int Arch Allergy Immunol
View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...